Regence Logos
Search: 
spacer
spacer
  » Medical Policy
  » Medication Policy
  » Dental Policy
  » Behavioral Health Policy
  » Clinical Position Statements
  » ConsumerTx
spacer


Browse alphabetically for topics addressed in TRG Medical Policies:
Medical Policy

Index

Please note: We are continually adding items to improve this index. If you are unable to find the term you are looking for, may we suggest you use the search engine at the top of this page to conduct a search for the term.

Last updated:  (November 1, 2009)

U
Ulcerative colitis; allogeneic
Ulcerative colitis; autologous
Ulcers, electrical stimulation
Ultra rapid detoxification
Ultrafast CT
Ultrasound ablation of uterine fibroids
Ultrasound based wireless pressure sensor; aneurysm
Ultrasound, noncontact wound healing
Unknown primary origin cancer; autologous
Upper airway resistance syndrome
Upper airway resistance syndrome, minimally invasive procedures
Upright magnetic resonance imaging (MRI)
Urgent® PC Neuromodulation System
Urinary biomarkers, Alzheimer's disease
Urinary incontinence, pelvic floor stimulation
Urinary tract obstruction, fetal surgery
URYX® urethral bulking agent
USGI scopes
Uterine cancer; allogeneic
Uterine cancer; autologous
Uterine leiomyoma, high intensity ultrasound ablation
Uvulopalatopharyngoplasty (UPPP)

 

Comments from physicians and other health care practitioners regarding TRG medical policies are welcome. If you are a physician and have a question or comment regarding a medical policy, please contact the medical policy staff through our secure form.
The Blue Cross and/or Blue Shield Plans comprising The Regence Group serve Idaho, Oregon, Utah and much of Washington state.
The Regence Group and each of its affiliate Plans are independent licensees of the Blue Cross and Blue Shield Association.